Literature DB >> 30712778

The different clinical value of susceptibility vessel sign in acute ischemic stroke patients under different interventional therapy: A systematic review and meta-analysis.

Mingsu Liu1, Lin Li1, Guangqin Li2.   

Abstract

Acute ischemic stroke (AIS) subtype, one of the most important factors for selecting therapeutic strategies, is difficult to be accurately diagnosed at admission sometimes. The magnetic susceptibility effect of deoxygenated hemoglobin in red thrombi appeared as hypointense signals in magnetic resonance imaging (MRI) scans. The prognostic value of susceptibility vessel sign (SVS) for stroke subtype, recanalization and outcomes in AIS patients will be comprehensively determined in the present study. A comprehensive search of databases was conducted including the PubMed, Embase, and Cochrane Library from inception up to August 2017. Statistical tests were performed to check for heterogeneity and publication bias. Subgroup and sensitivity analysis were also conducted to evaluate the robustness of the conclusions. Overall, 21 studies including 1832 patients were identified. The presence of SVS was significantly associated with cardioembolic stroke than absence of SVS (RR = 1.53, 95% CI = 1.30-1.81, p < 0.001). The patients with SVS were less likely to achieve recanalization (RR = 0.70, 95% CI = 0.56-0.88, p = 0.002) and poor functional outcome (RR = 1.68, 95% CI = 1.44-1.97, p < 0.001) after intravenous thrombolysis (IVT), whereas it was similar between two group after endovascular treatment (EVT) (p = 0.990 and p = 0.335). The SVS length was smaller in recanalization group than that in non-recanalization group (RR = -0.49, 95% CI = -0.72 to -0.27, p < 0.001), however, no significant difference between SVS width and recanalization rate was found. The presence of SVS appears to be a stronger predictor of cardioembolic stroke. Furthermore, the SVS was associated with a decreasing recanalization rate and poor outcome in AIS patients after IVT but not after EVT. Which offered a practical information to select optimal therapeutic strategies for stroke patients with SVS though the level of evidence seems to be quite shaky.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Meta-analysis; Stroke; Susceptibility vessel sign

Mesh:

Year:  2019        PMID: 30712778     DOI: 10.1016/j.jocn.2019.01.002

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Predictive value of thrombus susceptibility for cardioembolic stroke by quantitative susceptibility mapping.

Authors:  Jie Chen; Zhe Zhang; Ximing Nie; Yuyuan Xu; Chunlei Liu; Xingquan Zhao; Yongjun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-01

2.  Risk Factors of Recurrent Stroke in Young and Middle-Aged Stroke Patients after Interventional Therapy.

Authors:  Xin Dai; Fang Wang; Haiyang Lv; Xiuling Cheng
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

3.  Factors That Influence Susceptibility Vessel Sign in Patients With Acute Stroke Referred for Mechanical Thrombectomy.

Authors:  Manon Dillmann; Louise Bonnet; Fabrice Vuillier; Thierry Moulin; Alessandra Biondi; Guillaume Charbonnier
Journal:  Front Neurol       Date:  2022-05-11       Impact factor: 4.086

4.  Basilar artery thrombus magnetic susceptibility for cardioembolic stroke identification.

Authors:  Jie Chen; Zhe Zhang; Ximing Nie; Yuyuan Xu; Chunlei Liu; Xingquan Zhao; Yongjun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-02

5.  Absence of Susceptibility Vessel Sign in Patients With Malignancy-Related Acute Ischemic Stroke Treated With Mechanical Thrombectomy.

Authors:  Morin Beyeler; Nebiyat F Belachew; Moritz Kielkopf; Enrique B Aleman; Alejandro Xavier León Betancourt; Kotryna Genceviciute; Christoph Kurmann; Lorenz Grunder; Barbara Birner; Thomas R Meinel; Adrian Scutelnic; Philipp Bücke; David J Seiffge; Tomas Dobrocky; Eike I Piechowiak; Sara Pilgram-Pastor; Heinrich P Mattle; Pasquale Mordasini; Marcel Arnold; Urs Fischer; Thomas Pabst; Jan Gralla; Martin D Berger; Simon Jung; Johannes Kaesmacher
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.